
|Articles|March 22, 2019 (Updated: November 15, 2020)
Deloitte Launches 10th Annual Accounting and Financial Report
Advertisement
Deloitte announced the release of its 10th annual accounting and financial reporting update for life sciences companies. The report includes a comprehensive guidance on how finance professionals can address emerging industry issues and trends.
Trends mentioned in the report included the shift from treatment to wellness, pricing pressures, digital technology expansion, and increased use of real-world data and other advances in science.
Read the full report
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
4
Real-World Data Brings New Insights to Natural History of Disease Studies
5




